Grant of options

RNS Number : 6694L

Circassia Pharmaceuticals Plc

01 May 2020

 

Grant of options

Oxford, UK - 1 May 2020:  Circassia Group plc ("Circassia" or "the Company"; LSE: CIR), a specialty biopharmaceutical company focused on respiratory disease, announces that it has today granted 6,806,199 nominal and nil-cost cost options ("Options") over new ordinary shares in the Company ("Ordinary Shares") to the Executive Directors under the 2019 Performance Share Plan.

Name	Price per Ordinary Share	Number of shares subject to award
Michael Roller	Nil	4,000,000
Ian Johnson	Nil	1,677,233
Jonathan Emms	0.08p	1,128,966

The Options will vest on the third anniversary of the date of grant and are exercisable until the tenth anniversary of the date of grant. Vesting is subject to either the price of an Ordinary Share reaching 62.4p for at least 30 consecutive dealing days or a liquidity event occurring above this level.

Contacts

Circassia Ian Johnson, Executive Chairman Michael Roller, Chief Financial Officer	c/o Peel Hunt
Peel Hunt (Nominated Adviser and Joint Broker) James Steel / Oliver Jackson	Tel: [phone]
finnCap (Joint Broker) Geoff Nash / Alice Lane	Tel: [phone]
Numis Securities (Joint Broker) James Black / Freddie Barnfield	Tel: [phone]

Notification and public disclosure of transactions by persons discharging managerial responsibilities and persons closely associated with them

1.	Details of the person discharging managerial responsibilities / person closely associated
a.	Name	Ian Johnson Michael Roller Jonathan Emms
2.	Reason for the notification
a.	Position/status	Executive Chairman Chief Financial Officer Chief Operating Officer
b.	Initial notification /Amendment	Initial notification
3.	Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor
a.	Name	Circassia Group plc
b.	LEI	2138006YAT138TOGA556
4.	Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted
a.	Description of the Financial instrument, type of instrument Identification code	Options over Ordinary shares of 0.08p each. GB00BJVD3B28 ISIN for the Ordinary shares
b.	Nature of the transaction	Award of share options granted under the 2019 Performance Share Plan over Ordinary Shares in Circassia
c.	Price(s) and volume(s)	Price(s) Volume(s) nil 4,000,000 nil 1,677,233 0.08p 1,128,966
d.	Aggregated information · Aggregated volume · Price	n/a
e.	Date of the transaction	1 May 2020
f.	Place of the transaction	Outside a trading venue

 

END

 

 

DSHGZGGKGMKGGZM